Compare SDA & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDA | TMCI |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | China | United States |
| Employees | 544 | N/A |
| Industry | Blank Checks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.2M | 120.4M |
| IPO Year | N/A | 2021 |
| Metric | SDA | TMCI |
|---|---|---|
| Price | $1.05 | $1.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | $4.75 | ★ $4.77 |
| AVG Volume (30 Days) | 155.4K | ★ 821.7K |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | $12.01 | N/A |
| Revenue Next Year | $15.55 | $8.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $1.03 | $1.17 |
| 52 Week High | $3.65 | $7.78 |
| Indicator | SDA | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 16.70 | 58.23 |
| Support Level | N/A | $1.77 |
| Resistance Level | $2.18 | $2.01 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 0.79 | 47.06 |
SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.